Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | NOS3 | P29474 | 2/20 | 0.32 |
| ▸ | NOS1 | P29475 | 2/20 | 0.32 |
| ▸ | NOS2 | P35228 | 2/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | CA4 | P22748 | 1/20 | 0.32 |
| ▸ | TRIM24 | O15164 | 2/20 | 0.32 |
| ▸ | TRIM33 | Q9UPN9 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | SHBG | P04278 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6889662 | 1.00 | ALDH1A1 (0.42) | ALDH1A1MAPTNOS3NOS1NOS2 | |
| SCHEMBL28066099 | 1.00 | ALDH1A1 (0.42) | ALDH1A1MAPTNOS3NOS1NOS2 | |
| SCHEMBL7009533 | 1.00 | ALDH1A1 (0.42) | ALDH1A1MAPTNOS3NOS1NOS2 | |
| SCHEMBL1865812 | 1.00 | ALDH1A1 (0.42) | ALDH1A1MAPTNOS3NOS1NOS2 | |
| SCHEMBL4864165 | 0.97 | ALDH1A1 (0.40) | ALDH1A1MAPTNOS3NOS1NOS2 | |
| SCHEMBL3975742 | 0.97 | ALDH1A1 (0.40) | ALDH1A1MAPTNOS3NOS1NOS2 | |
| SCHEMBL11593525 | 0.95 | ALDH1A1 (0.35) | ALDH1A1MAPTTRIM24TRIM33SHBG | |
| SCHEMBL16512839 | 0.95 | ALDH1A1 (0.35) | ALDH1A1MAPTTRIM24TRIM33SHBG | |
| SCHEMBL10514312 | 0.90 | TRIM24 (0.41) | ALDH1A1MAPTTRIM24TRIM33 | |
| SCHEMBL1244592 | 0.90 | ALDH1A1 (0.42) | ALDH1A1MAPTNOS1NOS2CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1998012156-A1 | COMBINATORIAL APPROACH FOR GENERATING NOVEL COORDINATION COMPLEXES | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 1998-03-26 | — | — | WO | claimed |
| CN-108358780-B | Method for synthesizing alpha-acyloxo cyclic ketone compound with high diastereoselectivity | 广东工业大学 | 2022-04-19 | — | — | CN | disclosed |
| US-20040235023-A1 | Parallel combinatorial approach to the discovery and optimization of catalysts and uses thereof | JACOBSEN ERIC N (US) | 2004-11-25 | — | — | US | disclosed |
| US-6709824-B2 | SCREENING SAMPLE FOR CATALYST; GENERATE LIBRARY OF CATALYST, SCREEN LIBRARY, RECOVER CATALYST | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 2004-03-23 | — | — | US | disclosed |
| US-6489093-B1 | THE PRESENT INVENTION PROVIDES METHODS AND COMPOSITIONS, I.E. SYNTHETIC LIBRARIES OF BINDING MOITIES, FOR METAL ATOM OR TO NON-METAL IONS, E.G., CATIONIC OR ANIONIC MOLECULES. | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 2002-12-03 | — | — | US | disclosed |
| US-20020102612-A1 | Parallel combinatorial approach to the discovery and optimization of catalysts and uses thereof | JACOBSEN ERIC N (US) | 2002-08-01 | — | — | US | disclosed |
| EP-0921125-B1 | 1,3,8-Triazaspiro[4,5]decan-4-on derivatives | HOFFMANN LA ROCHE (CH) | 2002-01-30 | — | — | EP | disclosed |
| US-6316616-B1 | USED AS CATALYST TO CATALYZE A CHEMOSELECTIVE, REGIOSELECTIVE, STEREOSELECTIVE OR ENANTIOSELECTIVE TRANSFORMATION | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 2001-11-13 | — | — | US | disclosed |
| US-6043366-A | USEFUL IN TREATING DISORDERS INVOLVING THE ORPHANIN FQ(A SEVENTEEN AMINO ACID LONG PEPTIDE) RECEPTOR. | HOFFMAN-LA ROCHE INC. (US) | 2000-03-28 | — | — | US | disclosed |
| EP-0921125-A1 | 1,3,8-Triaza-spiro 4,5 decan-4-on derivatives | F. HOFFMANN-LA ROCHE AG (CH) | 1999-06-09 | — | — | EP | disclosed |
| WO-1998012156-A1 | COMBINATORIAL APPROACH FOR GENERATING NOVEL COORDINATION COMPLEXES | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 1998-03-26 | — | — | WO | disclosed |
| US-4008184-A | 6,10 Dimethyl bicyclo(4,4,0)decane or decene alcohol and ester perfume compositions | FIRMENICH S.A. (CH) | 1977-02-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020102612-A1 | Parallel combinatorial approach to the discovery and optimization of catalysts and uses thereof | COASY, DCXR, LSS | ALDH1A1 741/4885MAPT 4194/4885NOS3 2338/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.